LTZ-301

· LTZ Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LTZ-301, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma [Phase 1]